A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose

Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine

(2021) Vivette D. D’Agati et al.   KIDNEY INTERNATIONAL

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

(2021) Nicole Doria-Rose et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine

(2021) Hirotaka Komaba et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273

(2021) Deborah Steensels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Minimal change disease following vaccination for SARS-CoV-2

(2021) Nicoletta Mancianti et al.   JOURNAL OF NEPHROLOGY

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine

(2021) Fadi Salem et al.   Kidney International Reports

De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?

(2021) Andrew S. Bomback et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan

(2021) Keiichi Matsuzaki et al.   Clinical and Experimental Nephrology

New‐onset autoimmune phenomena post‐COVID‐19 vaccination

(2021) Yue Chen et al.   IMMUNOLOGY

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Minimal Change Disease

(2016) Marina Vivarelli et al.   Clinical Journal of the American Society of Nephrology